4.6 Article

Novel Aeromonas Phage Ahy-Yong1 and Its Protective Effects against Aeromonas hydrophila in Brocade Carp (Cyprinus aka Koi)

期刊

VIRUSES-BASEL
卷 14, 期 11, 页码 -

出版社

MDPI
DOI: 10.3390/v14112498

关键词

Aeromonas hydrophila; phage; therapy; brocade carp; genome

类别

资金

  1. National key research and development program
  2. Key research and development project of Ningbo [2018YFA0903000]
  3. Key laboratory of marine biogenetic resources of State Oceanic Administration [2022Z170]
  4. K.C. Wong Magna Fund of Ningbo University [HY201602]

向作者/读者索取更多资源

Ahy-yong1 is a newly discovered phage that can effectively treat multi-antibiotic-resistant pathogen A. hydrophila. It has showed strong biofilm removal capacity and protective effect in fish.
Aeromonas hydrophila is a zoonotic pathogen and an important fish pathogen. A new lytic phage, Ahy-yong1, against multi-antibiotic-resistant pathogen A. hydrophila was isolated, identified, and tentatively used in therapy. Ahy-yong1 possesses a head of approximately 66 nm in diameter and a short tail of approximately 26 nm in length and 32 nm in width. Its complete dsDNA genome is 43,374 bp with a G + C content of 59.4%, containing 52 predicted opening reading frames (ORFs). Taxonomic analysis indicated Ahy-yong1 as a new species of the Ahphunavirus genus of the Autographiviridae family of the Caudoviricetes class. Ahy-yong1 was active only against its indicator host strain among the 35 strains tested. It is stable at 30-40 degrees C and at pH 2-12. Aeromonas phage Ahy-yong1 revealed an effective biofilm removal capacity and an obvious protective effect in brocade carp (Cyprinus aka Koi). The average cumulative mortality for the brocade carp in the blank groups intraperitoneally injected with PBS was 1.7% +/- 2.4%;for the control groups treated with A. hydrophila (10(8) CFU/fish) via intraperitoneal injection, it was 100.00%;and for the test group I, successively treated with A. hydrophila (10(8) CFU/fish) and Aeromonas phage Ahy-yong1 (10(7) PFU/fish) via intraperitoneal injection witha time interval of 2 hours, it was only 43.4% +/- 4.7%. Furthermore, the cumulative mortality of the test group II, successively treated with Aeromonas phage Ahy-yong1 (10(7) PFU/fish) and A. hydrophila (10(8) CFU/fish), was only 20.0% +/- 8.2%, and that of the test group III, simultaneously treated with Aeromonas phage Ahy-yong1 (10(7) PFU/fish) and A. hydrophila (10(8) CFU/fish), was only 30.0% +/- 8.2%. The results demonstrated that phage Ahy-yong1 was very effective in the therapies against A. hydrophila A18, prophylaxis was more effective than rescue, and earlier treatment was better for the reduction of mortality. This study enriches knowledge about Aeromonas phages.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据